All news

A passive stake exceeds 5% at Whitehawk Therapeutics (WHWK), with two parties reporting the same shares.

Alpha Vantage · Stock Titan · · AI-summarised by FinFlash

Dellora Investments LP and its principal, Kevin Pyun, have each reported a 5.6% passive stake in Whitehawk Therapeutics (WHWK), amounting to 3,169,287 shares of common stock. Both parties hold shared voting and dispositive power over these shares but explicitly disclaim beneficial ownership under Rule 13d-4.

Read original source

WHWK company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.